MedPath

ocal and systemic antibody responses for maintaining gingival health

Completed
Conditions
gum inflammation
periodontitis
10002252
Registration Number
NL-OMON41332
Lead Sponsor
Academisch Centrum Tandheelkunde Amsterdam (ACTA)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

* >18 and < 60 years of age
* DPSI-score between 0 and 3- for healthy controls
* No bone loss visible on radiograph for healthy controls
* Bleeding on probing for periodontitis patients
* Periodontitis patients diagnosed with periodontitis according to definition by Tonetti & Claffey (2005, Journal of Clinical Periodontology) : proximal attachment loss of * 3 mm in * 2 non-adjacent teeth
* Otherwise healthy
* Informed written consent

Exclusion Criteria

* <18 and >60 years of age
* Used antibiotics in the last 3 months
* People receiving immunosuppressive therapy or taking other immunomodulating agents
* Having received periodontal treatment <2 years ago or in periodontal maintenance

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>From each patient, the relative frequencies of B- and T-cell subsets will be<br /><br>determined, both in tissue and blood. These parameters will be compared between<br /><br>patients and controls. Additionally, immunohistochemical analysis of paraffin<br /><br>embedded biopsies will be performed to assess overall morphology and cell types<br /><br>present. Finally, antibodies will be cloned from single sorted plasma cells,<br /><br>and these will be tested for their (auto-) reactivity. This will all be related<br /><br>to the bacterial composition in periodontitis. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>nvt</p><br>
© Copyright 2025. All Rights Reserved by MedPath